
This article examines the mental and emotional changes that may occur during GLP-1 therapy. It reviews how these medications work, their potential effects on body image, and the role of psychological support. The aim is to provide clear, practical insight to support informed and balanced care decisions.
GLP-1 Medications and Their Mechanisms

GLP-1 receptor agonists play a key role in weight management and blood sugar control. They mimic natural hormones that regulate appetite and insulin release, which explains both their benefits and possible side effects.
Effects of GLP-1s on Mood

Clinical Findings on Mood Improvements
Some research suggests a more positive mental health profile for GLP-1 therapy. A 2024 clinical trial funded by Novo Nordisk found no increased risk of depression among users without prior psychiatric conditions. The study reported a small but statistically significant reduction in depressive symptoms.
Psychological Side Effects and Safety Concerns

Potential for Psychiatric Adverse Reactions
Psychiatric adverse effects appear uncommon but warrant attention. An analysis of the EudraVigilance database found that psychiatric reactions made up about 1.2% of reports for GLP-1 medications such as semaglutide and liraglutide. While the rate is low, the potential severity matters.
Reported effects range from anxiety and depression to more serious symptoms. A 2024 case report presented at the American Psychiatric Association meeting described severe delusional symptoms and a suicide attempt after starting Ozempic, with resolution after discontinuation.
These findings suggest that serious psychiatric events are rare but possible. Risk may be higher for patients with a prior mental health history, and suicidal risk remains an active focus of ongoing review.
Motivation, Reward, and Behavior Changes
Appetite Suppression and Food Motivation
GLP-1 medications strongly reduce appetite, which can ease “food noise” for many. Lower hunger and fewer cravings make it easier to reduce intake and support weight loss, a common goal in metabolic care.
For some, this shift can feel disruptive. Eating may start to feel like a task rather than a need. In patients with a history of restrictive eating disorders, such as anorexia, appetite suppression may reinforce harmful patterns. GLP-1 therapy is not appropriate for those who are under-eating or at risk of nutritional deficiency.
GLP-1s and Body Image

Changing Self-Perception During Weight Loss
Weight loss medications such as Ozempic and Wegovy can strongly affect body image and self-acceptance. As weight changes, self-perception often shifts as well. Seeing a different reflection can feel exciting, but it may also feel unfamiliar as the mind adjusts to physical change.
This transition can be emotionally layered. Compliments may feel affirming yet uncomfortable at the same time. Some patients describe a tension between appreciating progress and honoring who they were before, highlighting the challenge of integrating past and present identity during rapid physical change.
Addressing Stigma and Self-Acceptance

Navigating Societal Attitudes Toward Weight
In the United States, attitudes toward weight are often conflicting. Obesity is frequently framed as a personal or societal burden, yet people using effective treatments may still face criticism for not losing weight “the right way.”
This double standard can take a toll on mental health. Comments about cost, food choices, or reliance on medication can reinforce stigma and diminish progress. Seeking medical treatment for a health condition reflects informed care decisions, not personal failure.
At-Risk Groups for Mental Health Shifts

Identifying Who May Be More Vulnerable
People with a history of eating disorders face higher risk with GLP-1 therapy. Strong appetite suppression may reinforce restrictive behaviors and increase relapse risk. Careful screening and ongoing support from a mental health professional are recommended before considering treatment.
The Role of Past Trauma or Mental Health Conditions
A history of past trauma or pre-existing mental health conditions can significantly increase your vulnerability to mood shifts on GLP-1s. For some people, food is used as a coping mechanism to deal with the emotional pain of trauma, such as sexual abuse. When a medication removes that coping tool, underlying emotional issues can surface with great intensity.
Psychologists have seen patients who lose weight and become very fearful as they start to receive more attention. This can be especially true for trauma survivors, for whom weight may have served as a form of protection. The sudden physical change can leave them feeling exposed and emotionally raw.
Clinician Insights and Standard Guidelines
Provider Approaches for Monitoring Patients on GLP-1s
Effective patient monitoring is critical for safely prescribing a weight loss medication like a GLP-1. Healthcare providers are developing new approaches to track not just physical changes but also emotional and psychological side effects. This begins with screening patients for pre-existing psychiatric conditions before starting treatment.
During treatment, regular check-ins become essential. Providers should be asking specific questions about mood, anxiety, and any signs of suicidal ideation.
Discussion Points for Patients and Providers
Questions to Ask Before Starting GLP-1 Therapy
Before starting GLP-1 therapy, a focused discussion with a healthcare provider helps clarify how treatment may affect overall health, especially with existing conditions. Preparing questions ahead of time supports informed choices.
Mental health history should also be reviewed. Sharing current or past concerns, such as depression or anxiety, supports accurate risk assessment and safer care planning. These conversations are confidential and part of routine clinical practice.
Here are some important questions to ask your provider before starting treatment:
-
Given my personal and family history of mental health conditions, am I at a higher risk for psychological side effects?
-
What specific mood changes or emotional side effects should I watch for?
-
How will we monitor my mental health while I am on this medication?
-
What is the plan if I start to experience negative mood changes or other serious side effects?
How to Track Emotional and Psychological Side Effects
Your journal doesn't need to be elaborate. At the end of each day or week, take a few minutes to rate your mood, energy, and anxiety levels. Make note of your interest in hobbies and social activities. Did you feel unusually irritable or flat? Did you lose pleasure in things you normally enjoy?
When to Seek Additional Support or Referral
Knowing when to seek added support matters during GLP-1 therapy. Ongoing negative changes in mood or behavior should be raised early rather than ignored. A primary care provider is often the first contact and can coordinate further care if needed.
If depressive symptoms escalate, body image concerns become consuming, or thoughts of self-harm occur, prompt professional support is needed. Mental health clinicians, such as therapists or psychologists, are equipped to provide targeted care during these situations.
Remember, asking for help is a sign of strength. You should seek additional support or a referral if:
-
Your mood changes are persistent and negatively impacting your daily life or relationships.
-
You are experiencing any suicidal thoughts or feelings of hopelessness.
-
Your concerns about food or your body are becoming obsessive or feel like a developing eating disorder.
-
You feel like you need more tools to handle the emotional aspects of your weight loss journey.
Access Care Through Healthon

Research continues to examine how GLP-1 medications may affect mood alongside weight-related outcomes. Changes in motivation or body image can occur during treatment and deserve attention. Access to clinical guidance and mental health support can help address emotional side effects and support safe use. Healthon provides ongoing access to care teams and mental health resources when questions or concerns arise.
Frequently Asked Questions
Can GLP-1 medications cause mood changes or psychiatric side effects?
GLP-1 medications may be linked to mood changes or psychiatric effects in a small number of patients. While many report improved mental well-being, monitoring emotional changes and discussing concerns with a healthcare provider supports safe, personalized care.
Is there a link between GLP-1 drugs and suicidal thoughts?
Research suggests a possible association between GLP-1 medications and suicidal thoughts in a small subset of patients, though findings remain inconsistent. Ongoing monitoring is recommended. Any mental health concerns should be discussed promptly with a healthcare provider during treatment.
How might weight loss from GLP-1s impact my self-image?
Weight loss with GLP-1 therapy can improve self-image by supporting confidence and body acceptance. Some patients report greater social engagement and willingness to resume activities they once avoided, which may contribute to better mental well-being and a more balanced relationship with their bodies.
Reference List
-
Psych Obesity Review. (2024). Mood and appetite regulation via GLP-1 receptor agonists. https://www.apa.org/monitor/2025/07-08/weight-loss-drugs-mental-health#:~:text=One%20large%202024%20study%20in,the%20risk%20of%20major%20depression.
-
National Institutes of Health. (2023). GLP-1 receptor effects in the central nervous system. https://www.ncbi.nlm.nih.gov/books/NBK615014/
-
Midtown Practice. (n.d.). The gut–brain connection: Exploring GLP-1s and mental well-being.
https://midtownpractice.com/the-gut-brain-connection-exploring-glp-1s-and-your-mental-well-being/ -
American Psychological Association. (2025). Weight-loss drugs and mental health.
https://www.apa.org/monitor/2025/07-08/weight-loss-drugs-mental-health -
National Center for Biotechnology Information. (n.d.). GLP-1 receptor agonists and psychiatric outcomes.
https://pubmed.ncbi.nlm.nih.gov/40267815/ -
Nature Scientific Reports. (2024). Central nervous system effects of GLP-1 receptor activation.
https://www.nature.com/articles/s41598-024-75965-2 -
National Center for Biotechnology Information. (n.d.). Psychiatric safety signals associated with GLP-1 drugs.
https://pmc.ncbi.nlm.nih.gov/articles/PMC11084700/ -
National Center for Biotechnology Information. (n.d.). Case reports of neuropsychiatric effects during GLP-1 therapy.
https://pmc.ncbi.nlm.nih.gov/articles/PMC10669484/ -
News-Medical. (2025). Body image concerns drive interest in GLP-1 weight-loss drugs.
https://www.news-medical.net/news/20250423/Body-image-concerns-drive-interest-in-GLP-1-weight-loss-drugs-study-finds.aspx -
Psychology Today. (2025). Body image in the Ozempic era.
https://www.psychologytoday.com/us/blog/smart-people-dont-diet/202509/body-image-in-the-ozempic-era -
Rutgers University. (n.d.). How GLP-1s are shifting the story of weight, wellness, and self-acceptance.
https://camden.rutgers.edu/news/how-glp-1s-are-shifting-story-weight-wellness-and-self-acceptance -
Relief Mental Health. (n.d.). Mental health side effects of weight-loss drugs.
https://reliefmh.com/blog/the-mental-health-side-effects-of-weight-loss-drugs-like-ozempic-wegovy/ -
Think Global Health. (n.d.). The mental health effects of Ozempic and GLP-1 drugs.
https://www.thinkglobalhealth.org/article/the-mental-health-effects-of-ozempic-and-glp-1-drugs -
Penn Medicine. (n.d.). Semaglutide and mental health.
https://www.pennmedicine.org/news/semaglutide-and-mental-health - Oklahoma State University. (2024). Semaglutide research and brain-based effects.
https://news.okstate.edu/magazines/state-magazine/articles/2024/spring/brain_matters_osu-chs_researchers_studying_semaglutide_for_possible_addiction_treatment.html








